Authors:
Parnetti, L
Lanari, A
Amici, S
Gallai, V
Vanmechelen, E
Hulstaert, F
Citation: L. Parnetti et al., CSF phosphorylated tau is a possible marker for discriminating Alzheimer'sdisease from dementia with Lewy bodies, NEUROL SCI, 22(1), 2001, pp. 77-78
Authors:
Bergamaschini, L
Donarini, C
Foddi, C
Gobbo, G
Parnetti, L
Agostoni, A
Citation: L. Bergamaschini et al., The region 1-11 of Alzheimer amyloid-beta is critical for activation of contact-kinin system, NEUROBIOL A, 22(1), 2001, pp. 63-69
Citation: V. Gallai et al., Alzheimer's disease versus other degenerative dementias: from biology to treatment - Preface, MECH AGE D, 122(16), 2001, pp. 1921-1922
Authors:
Bottiglieri, T
Parnetti, L
Arning, E
Ortiz, T
Amici, S
Lanari, A
Gallai, V
Citation: T. Bottiglieri et al., Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: a study in an Italian population with dementia, MECH AGE D, 122(16), 2001, pp. 2013-2023
Authors:
Amenta, F
Parnetti, L
Gallai, V
Wallin, A
Citation: F. Amenta et al., Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches?, MECH AGE D, 122(16), 2001, pp. 2025-2040
Citation: L. Parnetti et al., Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data, MECH AGE D, 122(16), 2001, pp. 2041-2055
Authors:
Amici, S
Lanari, A
Romani, R
Antognelli, C
Gallai, V
Parnetti, L
Citation: S. Amici et al., Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina, MECH AGE D, 122(16), 2001, pp. 2057-2062
Authors:
Vanmechelen, E
Van Kerschaver, E
Blennow, K
De Deyn, PP
Galasko, D
Parnetti, L
Sindic, CJM
Arai, H
Riemenschneider, M
Hampel, H
Pottel, H
Valgaeren, A
Hulstaert, F
Vanderstichele, H
Citation: E. Vanmechelen et al., CSF-phospho-tau (181P) as a promising marker for discriminating Alzheimer's disease from dementia with Lewy bodies, ALZHEIMER'S DISEASE, 2001, pp. 285-291
Authors:
Sorbi, S
Alberoni, M
Alfieri, P
Vesuviana, S
Amici, S
Antana, D
Appollonio, I
Avanzi, S
Bartoli, A
Bergamasco, B
Bracco, L
Bruni, A
Terme, L
Bugiani, O
Caffarra, P
Caltagirone, C
Carolei, A
Casini, AR
Ciannella, L
Citterio, A
Daniele, A
D'Achille, G
Del Curatolo, G
Dell'Agnello, G
Durante, D
Farina, E
Ferrero, P
Forleo, P
Gainotti, G
Gabriele, P
Galante, E
Gallai, V
Gallassi, R
Gasparini, M
Ghetti, B
Giaccone, G
Girotti, F
Grimaldi, L
Grioli, S
Guarnieri, BM
Grottoli, S
Iemolo, F
Latorraca, S
Le Pira, F
Lenzi, GL
Lorusso, S
Mariani, C
Marcon, G
Mascia, V
Mearelli, S
Morante, M
Morbin, M
Musicco, M
Nardelli, E
Nichelli, P
Padovani, A
Paganini, M
Pantieri, R
Parisen, P
Parnetti, L
Passerella, B
Pettenati, C
Piacentini, S
Piccoli, F
Piccolini, C
Pizzolato, G
Provinciali, L
Pugliese, N
Redi, F
Ruggieri, RM
Ruggiero, U
Saetta, M
Schoenuber, R
Silveri, MC
Sorbi, S
Sorrentino, G
Sucapane, P
Stracciari, A
Tabaton, M
Tagliavini, F
Toso, V
Valluzzi, F
Citation: S. Sorbi et al., Guidelines for the diagnosis of dementia and Alzheimer's disease, NEUROL SCI, 21(4), 2000, pp. 187-194
Citation: V. Gallai et L. Parnetti, Stroke: Treatment, prevention and rehabilitation - Perugia 1st International Stroke Meeting, Perugia, Italy, November 26-27, 1999 - Preface, CEREB DIS, 10, 2000, pp. 1-1
Authors:
Bergamasco, B
Frattola, L
Muratorio, A
Piccoli, F
Mailland, F
Parnetti, L
Citation: B. Bergamasco et al., Alpha-dihydroergocryptine in the treatment of de novo parkinsonian patients: results of a multicentre, randomized, double-blind, placebo-controlled study, ACT NEUR SC, 101(6), 2000, pp. 372-380
Authors:
Leys, D
Erkinjuntti, T
Desmond, DW
Schmidt, R
Englund, E
Pasquier, F
Parnetti, L
Ghika, J
Kalaria, RN
Chabriat, H
Scheltens, P
Bogousslavsky, J
Citation: D. Leys et al., Vascular dementia: The role of cerebral infarcts, ALZ DIS A D, 13, 1999, pp. S38-S48
Authors:
Tayebati, SK
Codini, M
Gallai, V
Mannino, F
Parnetti, L
Ricci, A
Sarchielli, P
Amenta, F
Citation: Sk. Tayebati et al., Radioligand binding assay of M1-M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes, J NEUROIMM, 99(2), 1999, pp. 224-229